P2x7 deficiency suppresses development of experimental autoimmune encephalomyelitis
Open Access
- 8 August 2008
- journal article
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 5 (1) , 33
Abstract
Background: The purinergic receptor P2x7 is expressed on myeloid cells as well as on CNS glial cells, and P2x7 activation has been shown to increase both glial and T-cell activation. These properties suggest a role in the development of autoimmune disease including multiple sclerosis.Methods: The animal model of MS, experimental autoimmune encephalomyelitis (EAE) using myelin oligodendrocyte glycoprotein (MOG) peptide residues 35–55 was induced in wildtype C57BL6 mice and in P2x7 deficient mice ('P2x7 mice') that were backcrossed to C57BL6 mice. Disease progression was monitored by appearance of clinical signs, immunocytochemical staining to assess brain inflammation and neuronal damage, and by measurement of Tcell cytokine production.Results: The incidence of EAE disease in P2x7 mice was reduced 4-fold compared to the wildtype mice; however the P2x7 mice that became ill had similar days of onset and clinical scores as the wildtype mice. Splenic T-cells isolated from P2x7 null mice produced greater IFNγ and IL-17 (from 3 to 12 fold greater levels) than wildtype cells, however cytokine production from P2x7 derived cells was not increased by a selective P2x7 agonist as was cytokine production from wildtype cells. Although infiltrating cells were detected in brains of both the P2x7 and wildtype mice, astroglial activation and axonal damage was reduced versus wildtype mice, and the distribution of astroglial activation was markedly distinct in the two strains. In contrast, microglial activation was similar in the two strains.Conclusion: P2x7 deficiency resulted in compensatory changes leading to increased T-cell cytokine production, and activated T-cells were detected in the brains of P2x7 null mice with no clinical signs. However, the greatly reduced incidence of disease suggests that an initiating event is absent in these mice, and points to a role for astroglial P2x7 in development of EAE disease.Keywords
This publication has 39 references indexed in Scilit:
- In vitro and in vivo evidence for a role of the P2X7 receptor in the release of IL-1β in the murine brainBrain, Behavior, and Immunity, 2008
- Activation of P2X7 receptors decreases glutamate uptake and glutamine synthetase activity in RBA‐2 astrocytes via distinct mechanismsJournal of Neurochemistry, 2007
- P2X7 receptor-mediated reactive oxygen and nitrogen species formation: from receptor to generatorsBiochemical Society Transactions, 2007
- Glutamate Receptor Expression in Multiple Sclerosis LesionsBrain Pathology, 2007
- Extracellular NAD and ATP: Partners in immune cell modulationPurinergic Signalling, 2007
- P2X7 receptors: Properties and relevance to CNS functionGlia, 2006
- Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotectionProceedings of the National Academy of Sciences, 2006
- P2X7 nucleotide receptors mediate caspase-8/9/3-dependent apoptosis in rat primary cortical neuronsPurinergic Signalling, 2005
- ATP regulates oligodendrocyte progenitor migration, proliferation, and differentiation: involvement of metabotropic P2 receptorsBrain Research Reviews, 2005
- The cytokine IL‐1β transiently enhances P2X7 receptor expression and function in human astrocytesGlia, 2004